Products
-
Q&A: Cannabis and Psychedelics in Canada: Conceptualizations and Communities
CourseThis recorded Q&A brings together the faculty from the Cannabis and Psychedelics in Canada: Conceptualizations and Communities course.
$10
-
Q&A: Cannabis and Psychedelics in Canada: Mechanisms of Action, Clinical Research and Therapeutic Applications
CourseThis recorded Q&A brings together the faculty from the Cannabis and Psychedelics in Canada: Mechanisms of Action, Clinical Research and Therapeutic Applications course.
$10
-
Q&A: Cannabis and Psychedelics in Canada: Legal Landscapes and Policy Pathways
CourseThis recorded Q&A brings together the faculty from the Cannabis and Psychedelics in Canada: Legal Landscapes and Policy Pathways course.
$10
-
Webinar: Cannabis & Psychedelics from Conceptualization to Care in Canada
CourseThis recorded webinar features instructors from the Cannabis and Psychedelics: From Conceptualization to Care in Canada course discussing whether or not cannabis is a psychedelic, why that matters, and to whom.
$10
-
Rick Doblin on the FDA's MDMA Decision and the Future of Psychedelic Therapy
CourseTimely insights from Rick Doblin on the FDA's decision on MDMA and its impact on psychedelic research and therapy in 2025.
Free
-
Balancing Safety & Access: Healing Trauma with Psychedelics
CourseDiscover how to balance safety with access in trauma healing. Explore pharmacology, ancestral trauma, and the role of psychedelics in therapeutic practices. Join diverse voices discussing innovative healing methods and their implications.
$5